Molecular signature of complex regional pain syndrome (CRPS) and its analysis

References

• Birklein F, O’Neill D, Schlereth T. Complex regional pain syndrome: an optimistic perspective. Neurology. 2015;84:89–96.
   PubMed Web of Science ®Google Scholar
• Harden RN, Bruehl S, Perez RSGM, et al. Validation of proposed diagnostic criteria (the “Budapest criteria”) for complex regional pain syndrome. Pain. 2010;150:268–274.
   PubMed Web of Science ®Google Scholar
• Bruehl S, Maihofner C, Stanton-Hicks M, et al. Complex regional pain syndrome: evidence for warm and cold subtypes in a large prospective clinical sample. Pain. 2016;157:1674–1681.
   PubMed Web of Science ®Google Scholar
• Resmini G, Ratti C, Gianlucs C, et al. Treatment of complex regional pain syndrome. Clin Cases Miner Bone Metab. 2015;12:26–30.
   PubMedGoogle Scholar
• van Velzen GAJ, Rombouts SARB, van Buchem MA, et al. Is the brain of complex regional pain syndrome patients truly different? Eur J Pain. 2016;20:1622–1633.
   PubMed Web of Science ®Google Scholar
• Borchers AT, Gershwin ME. The clinical relevance of complex regional pain syndrome type I: the emperor’s new clothes. Autoimmun Rev. 2017;16:22–33.
   PubMed Web of Science ®Google Scholar
• Bean DJ, Johnson MH, Kydd RR, et al. Factors associated with disability and sick leave in early complex regional pain syndrome type-1.”. Clin J Pain. 2016;32:130–138.
   PubMed Web of Science ®Google Scholar
• Moseley GL, Herbert RD, Parsons T, et al. Intense pain soon after wrist fracture strongly predicts who will develop complex regional pain syndrome: prospective cohort study. J Pain. 2014;15:16–23.
   PubMed Web of Science ®Google Scholar
• Pons T, Shipton EA, Williman J, et al. Potential risk factors for the onset of complex regional pain syndrome type 1: a systematic literature review. Anesthesiol Res Pract. 2015;956539.
   PubMed Web of Science ®Google Scholar
• Speck V, Schlereth T, Birklein F, et al. Increased prevalence of posttraumatic stress disorder in CRPS. Eur J Pain. 2016. DOI:10.1002/ejp.940
   PubMed Web of Science ®Google Scholar
• Meena S, Sharma P, Gangary SK, et al. Role of vitamin C in prevention of complex regional pain syndrome after distal radius fractures: a meta-analysis. Eur J Orthop Surg Traumatol. 2015;25:637–641.
   PubMedGoogle Scholar
• Choi JH, Yu KP, Yoon Y-S, et al. Relationship between HbA1c and complex regional pain syndrome in stroke patients with type 2 diabetes mellitus. Ann Rehabil Med. 2016;40:779–785.
   PubMedGoogle Scholar
• Dirckx M, Stronks DL, van Bodegraven-Hof EAM, et al. Inflammation in cold complex regional pain syndrome. Acta Anaesthesiol Scand. 2015;59:733–739.
   PubMed Web of Science ®Google Scholar
• Goebel A, Blaes F. Complex regional pain syndrome, prototype of a novel kind of autoimmune disease. Autoimmun Rev. 2013;12:682–686.
   PubMed Web of Science ®Google Scholar
• Bellingham GA, Smith RS, Morley-Forster P, et al. Use of near infrared spectroscopy to detect impaired tissue oxygen saturation in patients with complex regional pain syndrome type 1. Can J Anaesth. 2014;61:563–570.
   PubMed Web of Science ®Google Scholar
• Reichenberger ER, Alexander GM, Perreault MJ, et al. Establishing a relationship between bacteria in the human gut and complex regional pain syndrome. Brain Behav Immun. 2013;29:62–69.
   PubMed Web of Science ®Google Scholar
• Blair S, Chinthagada M, Hoppenstehdt D, et al. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthopaedica Belgica. 1998;64:448–451.
   PubMedGoogle Scholar
• Birklein F, Schmelz M, Schifter S, et al. The important role of neuropeptides in complex regional pain syndrome. Neurology. 2001;57:2179–2184.
   PubMed Web of Science ®Google Scholar
• Schinkel C, Gaertner A, Zaspel J, et al. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. ClinJ Pain. 2006;22:235–239.
   PubMed Web of Science ®Google Scholar
• Groeneweg JG, Huygen FJPM, Heijmans-Antonissen C, et al. Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. BMC Musculoskelet Disord. 2006;7:91.
   PubMed Web of Science ®Google Scholar
• Huygen FJPM, Ramdhani N, van Toorenenbergen A, et al. Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1. Immunol Lett. 2004;91:147–154.
   PubMed Web of Science ®Google Scholar
• Alexander GM, van Rijn MA, van Hilten JJ, et al. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005;116:213–219.
   PubMed Web of Science ®Google Scholar
• Uçeyler N, Eberle T, Rolke R, et al. Differential expression patterns of cytokines in complex regional pain syndrome. Pain. 2007;132:195–205.
   PubMed Web of Science ®Google Scholar
• Heijmans-Antonissen C, Wesseldijk F, Munnikes R, et al. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm. 2006;11:1–8.
   Web of Science ®Google Scholar
• Xu ZZ, Zhang L, Liu T, et al. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med. 2010;16:592–597.
   PubMed Web of Science ®Google Scholar
• Maihofner C, Handwerker HO, Neundorfer B, et al. Mechanical hyperalgesia in complex-regional pain syndrome: a role for TNF-alpha. Neurology. 2005;65:311–313.
   PubMed Web of Science ®Google Scholar
• Birklein F, Drummond PD, Li W, et al. Activation of cutaneous immune responses in complex regional pain syndrome. J Pain. 2014;15:485–495.
   PubMed Web of Science ®Google Scholar
• Osborne S, Farrell J, Dearman RJ, et al. Cutaneous immunopathology of long-standing complex regional pain syndrome. Eur J Pain. 2015;19:1516–1526.
   PubMed Web of Science ®Google Scholar
• Pepper A, Li W, Kingery WS, et al. Changes resembling complex regional pain syndrome following surgery and immobilization. J Pain. 2013;14:516–524.
   PubMed Web of Science ®Google Scholar
• Bruehl S. An update on the pathophysiology of CRPS. Anesthesiology. 2010;113:713–725.
   PubMed Web of Science ®Google Scholar
• Parkitny L, McAuley JH, Di Pietro F, et al. Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurol. 2013;80:106–117.
   PubMed Web of Science ®Google Scholar
• Sabsovich I, Guo T-Z, Wei T, et al. TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain. 2008;137:507–519.
   PubMed Web of Science ®Google Scholar
• Li WW, Sabsovich I, Guo TZ, et al. The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain. 2009;144:303–313.
   PubMed Web of Science ®Google Scholar
• Guo T-Z, Wei T, Shi X, et al. Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome. Mol Pain. 2012;8:85.
   PubMed Web of Science ®Google Scholar
• Wei T, Guo T-Z, Li -W-W, et al. Acute versus chronic phase mechanisms in a rat model of CRPS. J Neuroinflamm. 2016;13:14.
   PubMed Web of Science ®Google Scholar
• Hsiao H-T, Lin Y-C, Wang JC, et al. Hypoxia inducible factor-1 inhibition produced anti-allodynia effect and suppressed inflammatory cytokine production in early stage of mouse complex regional pain syndrome model. Clin Exp Pharmacol Physiol. 2016;43:355–359.
   PubMed Web of Science ®Google Scholar
• Martins DF, Prado MRB, Daruge-Neto E, et al. Caffeine prevents antihyperalgesic effect of gabapentin in an animal model of CRPS-I: evidence for the involvement of spinal adenosine A1 receptor. J Peripher Nerv Syst. 2015;20:403–409.
   PubMed Web of Science ®Google Scholar
• Ota H, Arai T, Iwatsuki K, et al. Pathological mechanism of musculoskeletal manifestations associated with CRPS type II: an animal study. Pain. 2014;155:1976–1985.
   PubMed Web of Science ®Google Scholar
• Wang L, Guo T-Z, Wie T, et al. Bisphosphonates inhibit pain, bone loss, and inflammation in a rat tibia fracture model of complex regional pain syndrome. Anesth Analg. 2016;123:1033–1045.
   PubMed Web of Science ®Google Scholar
• Boyle JJ. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol. 2005;3:63–68.
   PubMedGoogle Scholar
• Locksley RM, Killeen N, Lenardo MJ, et al. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487–501.
   PubMed Web of Science ®Google Scholar
• Kramer HH, Eberle T, Uceyler N, et al. TNF-alpha in CRPS and ‘normal’ trauma - Significant differences between tissue and serum. Pain. 2011;152:285–290.
   PubMed Web of Science ®Google Scholar
• Eberle T, Doganci B, Kramer HH, et al. Warm and cold complex regional pain syndromes: differences beyond skin temperature? Neurology. 2009;72(6):505–512.
   PubMed Web of Science ®Google Scholar
• Kramer HH, Hofbauer LC, Szalay G, et al. Osteoprotegerin: a new biomarker for impaired bone metabolism in complex regional pain syndrome? Pain. 2014;155:889–895.
   PubMed Web of Science ®Google Scholar
• Alexander GM, Peterlin BL, Perreault MJ, et al. Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome. J Pain. 2012;13:10–20.
   PubMed Web of Science ®Google Scholar
• Dirckx M, Groeneweg G, Wesseldijk F, et al. Report of a preliminary discontinued double-blind, randomized, placebo-controlled trial of the anti-TNFα chimeric monoclonal antibody infliximab in complex regional pain syndrome. Pain Pract. 2013;13:633–640.
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Sandler I, Treister R, et al. Antitumor necrosis factor-α adalimumab for complex regional pain syndrome type 1 (CRPS-I): a case series. Pain Pract. 2013;13:649–656.
   PubMed Web of Science ®Google Scholar
• Crabb Breen E, Reynolds SM, Cox C, et al. Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol. 2011;18:1229–1242.
   PubMed Web of Science ®Google Scholar
• Nahm FS, Park Z-Y, Nahm -S-S, et al. Proteomic identification of altered cerebral proteins in the complex regional pain syndrome animal model. BioMed Res Int. 2014;498410:1–11.
   Web of Science ®Google Scholar
• Oki G, Wada T, Iba K, et al. Metallothionein deficiency in the injured peripheral nerves of complex regional pain syndrome as revealed by proteomics. Pain. 2012;153:532–539.
   PubMed Web of Science ®Google Scholar
• Distler U, Kuharev J, Navarro P, et al. Label-free quantification in ion mobility-enhanced data-independent acquisition proteomics. Nat Prot. 2016;11:795–812.
   PubMed Web of Science ®Google Scholar
• Tajerian M, Hung V, Khan H, et al. Identification of KRT16 as a target of an autoantibody response in complex regional pain syndrome. Exp Neurol. 2017;287:14–20.
   PubMed Web of Science ®Google Scholar
• de Mos M, Huygen FJPM, Stricker BHC, et al. The association between ACE inhibitors and the complex regional pain syndrome: suggestions for a neuro-inflammatory pathogenesis of CRPS. Pain. 2009;142:218–224.
   PubMed Web of Science ®Google Scholar
• Kim KS, Kumar S, Simmons WH, et al. Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans. J Pharmacol Exp Therap. 2000;292:295–298.
   PubMed Web of Science ®Google Scholar
• Kawasaki Y, Xu ZZ, Wang X, et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med. 2008;14:331–336.
   PubMed Web of Science ®Google Scholar
• Weber M, Birklein F, Neundörfer B, et al. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain. 2001;91:251–257.
   PubMed Web of Science ®Google Scholar
• Raidoo DM, Bhoola KD. Kinin receptors on human neurons. J Neuroimmun. 1997;77:39–44.
   PubMed Web of Science ®Google Scholar
• Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 1993;16:99–104.
   PubMed Web of Science ®Google Scholar
• Chapman V, Dickenson AH. The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur J Pharmacol. 1992;219:427–433.
   PubMed Web of Science ®Google Scholar
• Koban M, Leis S, Schultze-Mosgau S, et al. Tissue hypoxia in complex regional pain syndrome. Pain. 2003;104:149–157.
   PubMed Web of Science ®Google Scholar
• Krämer HH, Eberle T, Uceyler N, et al. TNF-alpha in CRPS and ‘normal’ trauma - Significant differences between tissue and serum1. Pain. 2011;152:285–290.
   PubMed Web of Science ®Google Scholar
• Harper JI, Godwin H, Green A, et al. A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis. Br J Dermatol. 2010;162:397–403.
   PubMed Web of Science ®Google Scholar
• Baykal T, Seferoglu B, Karsan O, et al. Antioxidant profile in patients with complex regional pain syndrome type I. Int J Rheum Dis. 2014;17:156–158.
   PubMed Web of Science ®Google Scholar
• Byrd JB, Touzin K, Sile S, et al. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor-associated angioedema. Hypertension. 2007;51:141–147.
   PubMed Web of Science ®Google Scholar
• Pellacani A, Brunner HR, Nussberger J. Antagonizing and measurement: approaches to understanding of hemodynamic effects of kinins. J Cardiovasc Pharmacol. 1992;20:S28–34.
   PubMed Web of Science ®Google Scholar
• Lame ME, Chambers EE, Fountain KJ. An improved SPE-LC-MS/MS method for the quantification of bradykinin in human plasma using the ionKey/MS system. ionKey/MS Application Compendium. 2016;8–15.
   Google Scholar
• Baralla E, Nieddu M, Boatto G, et al. Quantitative assay for bradykinin in rat plasma by liquid chromatography coupled to tandem mass spectrometry. J Pharmac Biomed Anal. 2011;54:557–561.
   PubMed Web of Science ®Google Scholar
• Yi J, Kim C, Gelfand CA. Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J Proteome Res. 2007;6:1768–1781.
   PubMed Web of Science ®Google Scholar
• Bisswanger H. Enzyme assays. Persp Sci. 2014;1:41–55.
   Google Scholar
• Bayer M, Schildt A, Schlereth T, et al. Bradykinn degradation in CRPS. Proceed Münster Conf Biomol Anal. 2016. urn:nbn:de:hbz:6-83299734473.
   Google Scholar
• Bayer M, König S. A vote for robustness: monitoring serum enzyme activity by thin-layer chromatography of dabsylated bradykinin products. J Pharm Biomed Anal. 2017;143:199–203.
   PubMed Web of Science ®Google Scholar
• Glinge C, Clauss S, Boddum K, et al. Stability of circulating blood-based microRNAs – Pre-analytic methodological considerations. PLoS One. 2017;12(2):e0167969.
   PubMed Web of Science ®Google Scholar
• Shenoda BB, Ajit SK, Alexander GM. Hsa-miR-34a mediated repression of corticotrophin releasing hormone receptor 1 regulates pro-opiomelanocortin expression in patients with complex regional pain syndrome. J Transl Med. 2016;14:64.
   PubMed Web of Science ®Google Scholar
• Douglas SR, Shenoda BB, Qureshi RA, et al. Analgesic response to intravenous ketamine is linked to a circulating microRNA signature in female patients with complex regional pain syndrome. J Pain. 2015;16:814–824.
   PubMed Web of Science ®Google Scholar
• McDonald MK, Tian Y, Qureshi RA, et al. Functional significance of macrophage-derived exosomes in inflammation and pain. Pain. 2014;155:1527–1539.
   PubMed Web of Science ®Google Scholar
• Janicki PK, Eckert J, Postula M, et al. Analysis of common single nucleotide polymorphisms in complex regional pain syndrome: genome wide association study approach and pooled DNA strategy. Pain Med. 2016;17:2344–2352.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immun. 2008;8:349–361.
   PubMed Web of Science ®Google Scholar
• Fuchs B, Süß R, Teuber K, et al. Lipid analysis by thin-layer chromatography - A review of the current state. J Chrom A: Planar Chrom. 2011;1218:2754–2774.
   PubMed Web of Science ®Google Scholar
• Han X. Lipidomics – comprehensive mass spectrometry of lipids. In: Desiderio DM, Loo JA, editors. Wiley series on mass spectrometry. Hoboken (NJ): Wiley; 2016.
   Google Scholar
• Schildt A, Schlereth T, Birklein F, et al. Analyzing marker substances for CRPS. Mercator J Biomol Anal. 2017;1:1–23.
   Google Scholar
• Skarke C, Alamuddin N, Lawson JA, et al. Bioactive products formed in humans from fish oils. J Lipid Res. 2015;56:808–820.
   Web of Science ®Google Scholar
• Colas RA, Shinohara M, Dalli J, et al. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am J Physiol Cell Physiol. 2014;307:C39–C54.
   PubMed Web of Science ®Google Scholar
• Murphy RC. Specialized pro-resolving mediators: do they circulate in plasma? J Lipid Res. 2015;56:1641–1712.
   PubMed Web of Science ®Google Scholar
• Meissner A, van der Plas AA, van Dasselaar NT, et al. 1H-NMR metabolic profiling of cerebrospinal fluid in patients with complex regional pain syndrome-related dystonia. Pain. 2014;155:190–196.
   PubMed Web of Science ®Google Scholar
• Terkelsen AJ, Gierthmuhlen J, Petersen LJ, et al. Cutaneous noradrenaline measured by microdialysis in complex regional pain syndrome during whole-body cooling and heating. Exp Neurol. 2013;247:456–465.
   PubMed Web of Science ®Google Scholar
• Buryanov A, Kostrub A, Kotituk V. Endocrine disorders in women with complex regional pain syndrome type I. Eur J Pain. 2017;21:302–308.
   PubMed Web of Science ®Google Scholar
• Xie Y, Alexander GM, Schwartzman RJ, et al. Development and validation of a sensitive LC-MS/MS method for the determination of D-serine in human plasma. J Pharm Biomed Anal. 2014;89:1–5.
   PubMed Web of Science ®Google Scholar
• Grieve S, Perez RSGM, Birklein F, et al. Recommendations for a first core outcome measurement set for complex regional PAin syndrome Clinical studies (COMPACT). Pain. 2017;158:1083–1090.
   PubMed Web of Science ®Google Scholar